In the study by Velcheti et al. (25), the rate of PD-L1 expression was 69.2% in 13 cases with sarcomatoid carcinoma among 458 cases with NSCLC, and this rate was found to be 27.4% in other histological subtypes. This evidence concerns the gene CD274 and non-small cell lung carcinoma.